Because cytokine immunotherapy is a very promising mainstay of treatment for malignant melanoma, we also hypothesize that betulin may modulate the immune cell expression of IFN-γ and cytotoxic T cell effector mechanisms in vivo, which needs to be tested in the near future. This evidence concerns the gene IFNG and melanoma.